These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8466274)

  • 41. Bronchopulmonary dysplasia: treatment success with dexamethasone.
    Hearne AB
    J Natl Med Assoc; 1982 Aug; 74(8):795-800. PubMed ID: 7131578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dexamethasone for preterm infants at risk of bronchopulmonary dysplasia: is timing everything?
    Been JV; Simons SHP; Labrecque JA
    Eur Respir J; 2023 Oct; 62(4):. PubMed ID: 37857434
    [No Abstract]   [Full Text] [Related]  

  • 43. NO for preterm infants at risk of bronchopulmonary dysplasia.
    Sosenko IR; Bancalari E
    Lancet; 2010 Jul; 376(9738):308-10. PubMed ID: 20655103
    [No Abstract]   [Full Text] [Related]  

  • 44. L-selectin expression on polymorphonuclear leukocytes and monocytes in premature infants: reduced expression after dexamethasone treatment for bronchopulmonary dysplasia.
    Waisman D; Van Eeden SF; Hogg JC; Solimano A; Massing B; Bondy GP
    J Pediatr; 1998 Jan; 132(1):53-6. PubMed ID: 9470000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Neonatology; 2010; 98(4):289-96. PubMed ID: 20453523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On dexamethasone in bronchopulmonary dysplasia.
    Frank L
    Pediatr Pulmonol; 1994 Mar; 17(3):205-6. PubMed ID: 8197003
    [No Abstract]   [Full Text] [Related]  

  • 47. [Dexamethasone in the treatment of bronchopulmonary dysplasia].
    Schrod L; Frauendienst-Egger G; Forgber I; von Stockhausen HB
    Pneumologie; 1991 Nov; 45(11):892-6. PubMed ID: 1762998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dexamethasone therapy for bronchopulmonary dysplasia.
    Kramer LI
    Va Med Q; 1994; 121(4):239-40, 244. PubMed ID: 7948077
    [No Abstract]   [Full Text] [Related]  

  • 49. Dexamethasone for bronchopulmonary dysplasia.
    Donn SM; Faix RG; Banagale RC
    Lancet; 1983 Aug; 2(8347):460. PubMed ID: 6135948
    [No Abstract]   [Full Text] [Related]  

  • 50. Dexamethasone therapy in preterm infants developing bronchopulmonary dysplasia: effect on pulmonary surfactant disaturated-phosphatidylcholine kinetics.
    Cogo PE; Simonato M; Mariatoffolo G; Stefanutti G; Chierici M; Cobelli C; Ori C; Carnielli VP
    Pediatr Res; 2008 Apr; 63(4):433-7. PubMed ID: 18356753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Response to dexamethasone in ventilated preterm infants: effect of radiographic subtype of chronic lung disease.
    Kothadia JM; O'Shea TM; Auringer ST; Dillard RG
    Am J Perinatol; 1996 Aug; 13(6):377-81. PubMed ID: 8865986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dexamethasone and bronchopulmonary dysplasia.
    Frank L; Lecuona PC
    Pediatrics; 1996 Sep; 98(3 Pt 1):514-5. PubMed ID: 8784386
    [No Abstract]   [Full Text] [Related]  

  • 53. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
    Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dexamethasone therapy in severe bronchopulmonary dysplasia.
    Bourchier D
    Aust Paediatr J; 1988 Feb; 24(1):41-4. PubMed ID: 3355444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypothalamic-pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone.
    Alkalay AL; Pomerance JJ; Puri AR; Lin BJ; Vinstein AL; Neufeld ND; Klein AH
    Pediatrics; 1990 Aug; 86(2):204-10. PubMed ID: 2371095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurological adverse effects of early postnatal dexamethasone in very preterm infants.
    Baud O; Zupan V; Lacaze-Masmonteil T; Dehan M
    Arch Dis Child Fetal Neonatal Ed; 1999 Mar; 80(2):F159. PubMed ID: 10325800
    [No Abstract]   [Full Text] [Related]  

  • 57. Catabolic effect of dexamethasone in the preterm baby.
    Brownlee KG; Ng PC; Henderson MJ; Smith M; Green JH; Dear PR
    Arch Dis Child; 1992 Jan; 67(1 Spec No):1-4. PubMed ID: 1482427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Steroids, chronic lung disease, and retinopathy of prematurity.
    Ehrenkranz RA
    Pediatrics; 1992 Oct; 90(4):646-7. PubMed ID: 1408525
    [No Abstract]   [Full Text] [Related]  

  • 59. Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Neonatology; 2010; 98(3):217-24. PubMed ID: 20389126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Basal and post-ACTH cortisol levels in preterm infants following treatment with dexamethasone.
    Cronin CM; Dean H; MacDonald NT; Seshia MM
    Clin Invest Med; 1993 Feb; 16(1):8-14. PubMed ID: 8385590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.